You are here

Genentech

As biosimilars loom, Roche's Genentech plans to lay off 223 staffers in California

As biosimilars loom, Roche's Genentech plans to lay off 223 staffers in California

Fierce Pharma

Flag link:

Genentech, Horizon Earn Spots on List of ‘Companies That Care’

Genentech, Horizon Earn Spots on List of ‘Companies That Care’

BioSpace

Flag link:

Roche vaults into lead in frontline triple negative breast cancer as Tecentriq/Abraxane combo aces progression-free survival

Roche vaults into lead in frontline triple negative breast cancer as Tecentriq/Abraxane combo aces progression-free survival

Endpoints

triple negative breast cancer

Flag link:

Microbiome report for week ending 6-24-18

Microbiome report for week ending 6-24-18

CP Wire

Axial Biotherapeutics

Flag link:

Microbiome report for week ending 6-24-18

Axial Biotherapeutics

Flag link:

FDA Approves Genentech’s Rituxan For Rare Autoimmune Disease Pemphigus Vulgaris

FDA Approves Genentech’s Rituxan For Rare Autoimmune Disease Pemphigus Vulgaris

CP Wire

pemphigus vulgaris

Genentech/Roche

Flag link:

Genentech signs $534M deal with Microbiotica to search gut bacteria for IBD targets, new drugs

Genentech signs $534M deal with Microbiotica to search gut bacteria for IBD targets, new drugs

Fierce Biotech

Flag link:

Roche Up, J&J Down as Cancer Drug Combos Yield More Mixed Results

Roche Up, J&J Down as Cancer Drug Combos Yield More Mixed Results

Xconomy

clinical trials

Flag link:

Genentech allies with a metagenomics upstart in New York on a discovery deal jam packed with biobucks

Genentech allies with a metagenomics upstart in New York on a discovery deal jam packed with biobucks

Endpoints

Lodo Therapeutics

Flag link:

FDA promises Roche a snap decision on Tecentriq triple for frontline lung cancer as it falls even further behind Merck, Bristol-Myers

FDA promises Roche a snap decision on Tecentriq triple for frontline lung cancer as it falls even further behind Merck, Bristol-Myers

Endpoints

Flag link:

Genentech antibody spotlights new target for antibiotic-resistant bacteria

Genentech antibody spotlights new target for antibiotic-resistant bacteria

Fierce Biotech

antibiotic resistance

Flag link:

After FDA setback, Bellicum bolsters R&D team with ex-Genentech executive

After FDA setback, Bellicum bolsters R&D team with ex-Genentech executive

Fierce Biotech

Flag link:

[forum discussion]Over 50

[forum discussion]Over 50

Cafepharma Message Boards

Flag link:

Genentech beefs up its PD-L1 combo pipeline, signing the ‘don’t eat me’ specialists at Forty Seven

Genentech beefs up its PD-L1 combo pipeline, signing the ‘don’t eat me’ specialists at Forty Seven

Endpoints

anti-PD-1 immunotherapy

Flag link:

Roche Gains Ground on Rivals With Drug Combo’s Success in Lung Cancer

Roche Gains Ground on Rivals With Drug Combo’s Success in Lung Cancer

Xconomy

Flag link:

FDA Approves Genentech Hemophilia Drug, But Adds Safety Warning

FDA Approves Genentech Hemophilia Drug, But Adds Safety Warning

Xconomy

Flag link:

Genentech inks $650M deal with protein degradation pioneer Arvinas

Genentech inks $650M deal with protein degradation pioneer Arvinas

Endpoints

targeted protein degradation

Flag link:

Last week in pharma.bio.device.lab November 5-11 2017

Last week in pharma.bio.device.lab November 5-11 2017

CP Wire

Valeant Pharmaceuticals

physician payments

Flag link:

Amgen and Genentech are the latest drug makers to lay off workers

Amgen and Genentech are the latest drug makers to lay off workers

Stat

drug manufacturing

Flag link:

[forum discussion]Huge Headcount Reductions

[forum discussion]Huge Headcount Reductions

Cafepharma Message Boards

Flag link:

Pages